Human papillomavirus (HPV) tests manufactured in the United States are not subject to the Trump Administration’s tariffs, but “export challenges may arise for US manufacturers due to potential retaliatory tariffs,” says a GlobalData release.
GlobalData HPV Tests SKU tracking found that nearly 95% of HPV tests sold in the U.S. are also manufactured in the U.S. Selena Yu, Senior Medical Device Analyst at GlobalData emphasized “Tariffs can disrupt supply chains, creating uncertainty and delays, particularly if other nations impose retaliatory tariffs that could negatively affect US exports of medical devices.”
